Equities

Longduoduo Co Ltd

LDDD:PKC

Longduoduo Co Ltd

Actions
  • Price (USD)5.17
  • Today's Change-0.51 / -8.98%
  • Shares traded121.00
  • 1 Year change-92.59%
  • Beta--
Data delayed at least 15 minutes, as of May 28 2024 18:03 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Longduoduo Co Ltd is a China-based company mainly providing preventive care services. The Company mainly focuses on prevention of myocardial infarction, cerebral infarction, hemiplegia, and cardiovascular and cerebrovascular diseases. Working with its third-party healthcare service providers, the Company provides preventive healthcare solutions including health products, medical examinations and services. The Company mainly conduct its businesses in domestic market .

  • Revenue in USD (TTM)8.78m
  • Net income in USD1.77m
  • Incorporated2021
  • Employees--
  • Location
    Longduoduo Co Ltd4-419, 2Nd Light Hospital, Ordos StreetHUHEHAOTE 010000ChinaCHN
  • Phone+86 4 725104980
  • Websitehttp://www.longduoduo.net/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
American Oncology Network Inc1.34bn-15.48m86.78m1.53k------0.0648-2.07-2.07161.04-9.943.5333.539.26878,552.80-22.82---78.96--5.00---6.46--1.20-7.840.606--11.27----------
Cardiff Lexington Corp12.35m-2.15m94.39m2.00------7.64-1,023.97-1,089.8765.540.00580.7163--1.326,173,760.00-8.97-52.27-23.24--70.0857.44-12.53-58.31--1.130.4002--21.4549.15-1,701.81------
ProPhase Labs Inc28.72m-23.60m97.68m113.00--2.06--3.40-1.34-1.341.642.490.30985.810.7872254,115.00-25.450.9106-33.001.1218.4150.32-82.180.93251.73-20.420.1953665.78-63.8127.59-190.90--86.46--
Longduoduo Co Ltd8.78m1.77m155.13m--87.54389.7474.8617.670.05910.05910.29230.01335.06453.60134.94--114.14------95.04--22.55--1.04--0.00--17.93--99.48------
DLH Holdings Corp402.59m3.07m157.27m3.20k56.081.477.780.39070.1970.19727.687.501.17--6.57125,807.800.89245.381.117.2020.9220.560.76313.41--1.500.60690.00-4.8823.05-93.73-28.16-0.903--
Biodesix Inc54.85m-47.06m166.29m217.00------3.03-0.5465-0.54650.6308-0.05660.653--7.42252,760.40-56.02-55.60-82.08-80.9476.2759.53-85.80-105.15---3.711.18--28.4619.1620.32--106.31--
Data as of May 28 2024. Currency figures normalised to Longduoduo Co Ltd's reporting currency: US Dollar USD

Institutional shareholders

0.00%Per cent of shares held by top holders
HolderShares% Held
Andbank Wealth Management SGIIC SAUas of 31 Dec 20230.000.00%
Data from 31 Jan 2024 - 31 Jan 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.